Literature DB >> 3480235

Granular common acute lymphoblastic leukaemia in adults: a morphological study.

C R Hay1, D Barnett, V James, B W Woodcock, M J Brown, A C Lawrence.   

Abstract

2 cases of acute lymphoblastic leukaemia characterised by the presence of cytoplasmic inclusions morphologically similar to azurophil granules are described. Azurophil granulation of blasts is one of the cardinal features which differentiate acute myeloid from acute lymphoblastic leukaemia. Although such granulation of lymphoblasts has caused diagnostic confusion in the past, we found that the granules could be distinguished from myeloid azurophil granules both morphologically and by their characteristic cytochemical staining reactions. They were negative for peroxidase/sudan black and chloroacetate esterase, but gave coarse scattered granular positivity for both acid phosphatase and alpha-naphthyl acetate esterase. Both the electron microscopic appearance of the granules and their cytochemical staining reactions suggested that they were lysosomes. Granular ALL does not appear to be associated with any morphological subtype or karyotype; but is strongly associated with the common ALL phenotype. Its prognostic significance remains uncertain. It occurs more frequently than the small number of previous reports might suggest and, given the potential for misdiagnosis, should be more widely recognised.

Entities:  

Mesh:

Year:  1987        PMID: 3480235     DOI: 10.1111/j.1600-0609.1987.tb00773.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Granular acute lymphoblastic leukemia in a 15-year-old boy.

Authors:  J Cap; O Babusikova; E Kaiserova; R Panzer-Grünmayer
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 2.  Hypergranular acute lymphoblastic leukemia (ALL). Report of a case and review of the literature.

Authors:  I Schwarzinger; M Födinger; R Scherrer; M Wolzt; C Mannhalter; W Speiser
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.